CANNABINOIDS FOR MEDICAL PURPOSES?

With new discoveries comes

new realities.

And significant opportunities for niche problem solutions, process, system innovation and sustainable solutions, tech to service solutions. 

SVENSKA VERDE AB™ offers context, insight,  and clarity into the complex realities involved.

From micro to macro.


What are
What is Medical cannabis
How could this
SVENSKA VERDE AB Due to regulatory reforms
Risk and potential
SVENSKA VERDE AB SystemstheoryDesign
Since 2011
SVENSKA VERDE AB™ Greater outcomes
More Than
A SYSTEMATIC APPROACH
SVENSKA VERDE AB Neuropathic pain
Neuropathy
SVENSKAVERDEAB logo
Total market
Svenska Verde AB Kampanj 31 01 22

SVENSKA VERDE AB™ PROVIDES INSIGHT, CONTEXT AND CLARITY.

  • What are cannabinoids?
  • What is neuropathic pain?
  • What are complex cluster diagnoses?
  • How could this affect you?
  • How could this affect your business?

  • Why does any of it matter?

"WHAT ABOUT THE WHEN,

WHERE, HOW AND WHY?"

Seeing the outlines of the greater concerns

and complexities regarding the future of

medical cannabis products - all the way back before 2013, we identified a future blindspot and a need to prioritize on large data, cultural understanding, and regulatory development, while maintaining a strong focus on education and communication. 

Today SVENSKA VERDE AB™ rests on a 

10-year full-scale international systems

theoretical phenomenal analysis of

"Medical Cannabis". 

SVENSKA VERDE AB™ brings together

global research, human experience and internationally acclaimed senior clinical

expertise and competence to a greater complementary unity.

"Identify. Validate. Determine. Go!"

"ONE STEP AT A TIME.

FIRST PRINCIPLES. FIRST.

THEN ONE CAN START ALL THE FUN STUFF?"

Peter Dolving Spring Gothenburg 2021

PETER DOLVING
FOUNDER, CEO.

Peter Dolving is a multiple award-winning entrepeneur, performing artist and author from Gothenburg, Sweden. Over the last 25 years Peter has worked in more than 90 states around the world.

Faced with a chronic pain diagnose in 2013 Peter Dolving decided to take a deeper look at the complexities of cannabinoid pharmaceutical ingredients.


With 20 years international experience in organization, performing arts, education, communication and development - CEO and founder Peter Dolving provides direction and sheds light on the complexities of medical cannabis, complex cluster diagnoses and the human brain.

LECTURES

WORKSHOPS

BUSINESS

BRIEFS

UPDATES
ORIENTATION

Would you like to know more?

Feel free to to reach out to us - we’d love to talk to you!